FDA Offers to Pay for Antibacterial Drug Research

The FDA is taking proposals for antibacterial drug development and research into antibacterial drug resistance.

The agency is looking to award procurement contracts for research in clinical trial design, such as enrollment strategies, data collection streamlining, drug development tools, clinical endpoints, and statistical approaches; as well as in vitro, animal model, and/or pharmacokinetic studies in antibacterial drug development, including studies focused on special populations such as children and patients with renal or hepatic dysfunction.

FDA is also considering research that examines the use of rapid diagnostic tests and antibacterial drug susceptibility testing.